GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Days Inventory

ME Therapeutics Holding (XCNQ:METX) Days Inventory : 0.00 (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). ME Therapeutics Holding's Average Total Inventories for the three months ended in Feb. 2024 was C$0.00 Mil. ME Therapeutics Holding's Cost of Goods Sold for the three months ended in Feb. 2024 was C$0.00 Mil.

The historical rank and industry rank for ME Therapeutics Holding's Days Inventory or its related term are showing as below:

XCNQ:METX's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 194.42
* Ranked among companies with meaningful Days Inventory only.

ME Therapeutics Holding's Days Inventory stayed the same from Dec. 2022 (0.00) to Feb. 2024 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


ME Therapeutics Holding Days Inventory Historical Data

The historical data trend for ME Therapeutics Holding's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Days Inventory Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Days Inventory
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Days Inventory Get a 7-Day Free Trial - - - - -

Competitive Comparison of ME Therapeutics Holding's Days Inventory

For the Biotechnology subindustry, ME Therapeutics Holding's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ME Therapeutics Holding's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Days Inventory distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Days Inventory falls into.



ME Therapeutics Holding Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ME Therapeutics Holding's Days Inventory for the fiscal year that ended in Aug. 2023 is calculated as

Days Inventory (A: Aug. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Aug. 2022 ) + Total Inventories (A: Aug. 2023 )) / count ) / Cost of Goods Sold (A: Aug. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

ME Therapeutics Holding's Days Inventory for the quarter that ended in Feb. 2024 is calculated as:

Days Inventory (Q: Feb. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Nov. 2023 ) + Total Inventories (Q: Feb. 2024 )) / count ) / Cost of Goods Sold (Q: Feb. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ME Therapeutics Holding  (XCNQ:METX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

ME Therapeutics Holding's Inventory Turnover for the three months ended in Feb. 2024 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ME Therapeutics Holding's Inventory to Revenue for the three months ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


ME Therapeutics Holding Days Inventory Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines